Figure 7
Figure 7. EPO triggers STAT5 signaling in human ETV6-RUNX1+ ALL patient samples. CD19+ cells were isolated from ALL patients, grown in RPMI medium with or without EPO 20 U/mL for 1 hour, and lysates were analyzed by Western blot for STAT5 phosphorylation and BCL-XL expression. Only in ETV6-RUNX1+ patients with higher expression of EPOR was its ligand EPO able to trigger STAT5 signaling. BCL-XL expression was always higher in ETV6-RUNX1+ samples, although there was no difference in the presence or absence of EPO.

EPO triggers STAT5 signaling in human ETV6-RUNX1+ ALL patient samples. CD19+ cells were isolated from ALL patients, grown in RPMI medium with or without EPO 20 U/mL for 1 hour, and lysates were analyzed by Western blot for STAT5 phosphorylation and BCL-XL expression. Only in ETV6-RUNX1+ patients with higher expression of EPOR was its ligand EPO able to trigger STAT5 signaling. BCL-XL expression was always higher in ETV6-RUNX1+ samples, although there was no difference in the presence or absence of EPO.

Close Modal

or Create an Account

Close Modal
Close Modal